Savient Gets Nod To Fund Ch. 11 Sale With Cash Collateral
A Delaware bankruptcy judge Wednesday gave Savient Pharmaceuticals Inc. the go-ahead to use cash collateral to fund its stay in Chapter 11, enabling the drug developer to proceed with a planned...To view the full article, register now.
Already a subscriber? Click here to view full article